Search Results (905)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Del Chiaro, Marco | Person |
Why?
|
| Schulick, Richard | Person |
Why?
|
| Non-invasive sampling of DNA markers for pancreatic cancer screening | Grant |
Why?
|
| Messersmith, Wells | Person |
Why?
|
| NQO1 Inhibitors and Pancreatic Cancer Therapy | Grant |
Why?
|
| Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. | Academic Article |
Why?
|
| Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas Society. | Academic Article |
Why?
|
| Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer. | Academic Article |
Why?
|
| Advances in the management of pancreatic cancer. | Academic Article |
Why?
|
| ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. | Academic Article |
Why?
|
| Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy. | Academic Article |
Why?
|
| Diabetes and pancreatic cancer risk in a multiracial cohort. | Academic Article |
Why?
|
| High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. | Academic Article |
Why?
|
| Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. | Academic Article |
Why?
|
| Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer. | Academic Article |
Why?
|